Vaughn M Kailian's Net Worth

$1.28 Million

Who is Vaughn M Kailian?

Vaughn M Kailian has an estimated net worth of $1.28 Million. This is based on reported shares across multiple companies, which include PEPLIN INC, TriVascular Technologies, Inc., Radius Health, Inc., Verastem, Inc., Syndax Pharmaceuticals Inc, Pacira Pharmaceuticals, Inc., ARATANA THERAPEUTICS, INC., Conatus Pharmaceuticals Inc, Epizyme, Inc., Cerecor Inc., CEPHALON INC, CHIASMA, INC, VIACELL INC, MEMORY PHARMACEUTICALS CORP, and MILLENNIUM PHARMACEUTICALS INC.

SEC CIK

Vaughn M Kailian's CIK is 0001180429

Past Insider Trading and Trends

2004 was Vaughn M Kailian's most active year for acquiring shares with 3 total transactions. Vaughn M Kailian's most active month to acquire stocks was the month of April. 2011 was Vaughn M Kailian's most active year for disposing of shares, totalling 7 transactions. Vaughn M Kailian's most active month to dispose stocks was the month of September. 2003 saw Vaughn M Kailian paying a total of $476,273.52 for 152,988 shares, this is the most they've acquired in one year. In 2004 Vaughn M Kailian cashed out on 105,130 shares for a total of $1,757,500.00, their largest year based on trade value.